Keywords: strong, safety, data, theratechnologies, tesamorelin, canada, presented

Strong safety data on Theratechnologies' tesamorelin

Article | 05 November 2007

Canada's Theratechnologies presented strong data in a late-breaker presentation on the long-term safety and efficacy of tesamorelin, its growth hormone-releasing ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing